WeDaita

Research Digest

AI-curated papers, approvals, clinical compounds, and disclosures from drug discovery's leading sources.

Scored for relevance by WeDaita AI · Updated weekly · Not editorial content
Target Identification Drug Design Clinical Trials

Active trials, regulatory milestones, and methodology advances — covering the full translational pipeline from Phase I to approval.

  • Clinical Trial — Active and recently updated trials from ClinicalTrials.gov, AI-scored for therapeutic area relevance
  • Literature — Trial design, patient stratification, biomarker-driven enrollment, and methodology studies
  • Industry News — FDA and EMA designations, IND filings, regulatory announcements, and trial-related company news
All Clinical Trial Literature Industry News
Literature
140 Assessment of timing of evaluation of proteinuria decline to inform clinical trial design in focal segmental glomerulosclerosis: results from the PARASOL consortium
Jan 1, 2026 · Journal of Clinical and Translational Science · Abigail R. Smith; Laura H. Mariani; M. Helmuth
Literature
The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.
Jan 1, 2026 · Blood · Dai Chihara; J. Westin
Literature
Next-Generation Artificial Intelligence in Clinical Trial Design, Conduct, and Analysis: A Paradigm Shift in Clinical Research
Jan 1, 2026 · International Journal of Clinical Case Reports and Reviews · Ashish Pandey *; Ankit Galav; Komal Mittal